Results 211 to 220 of about 1,140,157 (349)

Psychological Safety and How it is Affected by Leadership-styles

, 2019
Alexander Sema, Christoffer von Uthmann
openalex   +1 more source

Cost‐utility analysis of nusinersen–risdiplam switch in patients with spinal muscular atrophy in Croatia: A discrete event simulation model

British Journal of Clinical Pharmacology, EarlyView.
Introduction In recent years, the treatment of spinal muscular atrophy (SMA), a rare disease, has significantly progressed, improving patients' survival and overall quality of life. However, current SMA treatments are expensive, and some (nusinersen) are very inconvenient for patients.
Andrej Belančić, Ivana Stević, Elvira Meni Maria Gkrinia, Dinko Vitezić, Slobodan Janković   +4 more
wiley   +1 more source

Reconsidering psychological safety from the perspective of personality organization levels. [PDF]

Nagoya J Med Sci
Fujie R, Ban N.
europepmc   +1 more source

Perish in Comfort? Psychological Safety, Creativity, and Conscientiousness

Weipeng Lin, Jaclyn Koopmann, Mo Wang, Yingxin Deng   +3 more
openalex   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

British Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale, Clare Guilding, Jennifer Koenig, Michael Okorie, Reecha Sofat, Simon Maxwell   +5 more
wiley   +1 more source

From retention to turnover: the paradoxical role of career optimism and the moderating effect of psychological safety. [PDF]

Front Psychol
Gong Z, Lu Y, Li M.
europepmc   +1 more source

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Psychological safety as a context-sensitive predictor of retention intentions: Gendered effects of supervisor support under caregiving-assumed conditions. [PDF]

PLoS One
Yoshimura M, Yamaguchi H.
europepmc   +1 more source

THE HIDDEN MECHANISMS OF TOXIC LEADERSHIP: A MULTILEVEL ANALYSIS OF HOW LEADER DARK TRAITS CREATE FEAR, SILENCE, AND REDUCED PSYCHOLOGICAL SAFETY IN ORGANIZATIONS

Abul Fazal Mohammad Ahsan Uddin
openalex   +1 more source

Work in Progress: Design and Preliminary Results of a Survey to Explore Relationships Between Faculty Mentoring, Engineering Doctoral Student Psychological Safety, and Work Outcomes [PDF]

Dorian Bobbett, Jeanne Sanders, Larkin Martini, Mark Huerta, Karin Jensen   +4 more
openalex   +1 more source